Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
ZVRA
Zevra Therapeutics Restructures for Rare Disease Focus
| 2024-12-07 |
PHARMACEUTICAL
Zevra Therapeutics Launches First FDA-Approved NPC Treatment
| 2024-11-22 |
PHARMACEUTICAL
Zevra Therapeutics secures FDA approval for Miplyffa™ to treat Niemann-Pick Disease Type C
| 2024-09-21 |
PHARMACEUTICAL
